5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer

Cancer. 1995 Aug 1;76(3):528-30. doi: 10.1002/1097-0142(19950801)76:3<528::aid-cncr2820760327>3.0.co;2-w.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Comment

MeSH terms

  • Adult
  • Aged
  • Antidotes / administration & dosage*
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / pathology
  • Female
  • Fluorouracil / administration & dosage*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Leucovorin / administration & dosage*
  • Male
  • Middle Aged
  • Pilot Projects
  • Recombinant Proteins

Substances

  • Antidotes
  • Antimetabolites, Antineoplastic
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Leucovorin
  • Fluorouracil